The research appears in the Journal of Controlled Release. Japan became the first country to approve boron neutron capture therapy (BNCT), a type of targeted radiotherapy for cancer, in 2020.
The cancer treatment boron neutron capture therapy (BNCT) requires patients to receive a drug that loads tumor cells with the element boron, which absorb a delivery of neutrons and decay in a ...
Utilizing TAE Life Science’s novel boron-10 drugs and Kyoto University Research Reactor (KURR) neutron source has generated significant pre-clinical data that may redefine the potential of BNCT ...
In recent years, Boron Neutron Capture Therapy (BNCT) has emerged as a cutting-edge cancer treatment technology, experiencing rapid development globally. Neuboron Medical Group (Neuboron), a ...
Broader implementation of BNCT, however, has been hampered by (1) limited access to neutron sources—until recently only available at non-hospital settings such as at nuclear research reactors ...
Many other countries are now building facilities. In 2020, Japan became the first country to approve boron neutron capture therapy (BNCT), a new highly targeted radiotherapy for cancer.